series-b
Stage
2020
Founded
3
Investors
About
Hoba Therapeutics develops immunotherapy treatments utilizing allogeneic natural killer (NK) cells for cancer treatment.
Explore Hoba Therapeutics ApS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.